Diversion of the host humoral response: A novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles

Journal of Leukocyte Biology

Volumn 95, Issue 6, 2014, Pages 983-991

  Deknuydt, Florence ^a   Nordström, Therése ^a   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

B cell; Immunoglobulin D; Influenzae; Nanoparticles; Nontypeable H; Toll like receptor

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN D ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BACTERIAL VIRULENCE; CELL DENSITY; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; MEMBRANE COMPONENT; MEMBRANE VESICLE; NONHUMAN; OUTER MEMBRANE VESICLE; PRIORITY JOURNAL; PURIFICATION; T LYMPHOCYTE;

B CELL; IMMUNOGLOBULIN D; NANOPARTICLES; NONTYPEABLE H. INFLUENZAE; TOLL-LIKE RECEPTOR;

ADAPTIVE IMMUNITY; B-LYMPHOCYTES; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, B-CELL; TOLL-LIKE RECEPTOR 9; VIRULENCE;

EID: 84901700533     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1013527     Document Type: Article

References (37)

1. Murphy, T. F., Faden, H., Bakaletz, L. O., Kyd, J. M., Forsgren, A., Campos, J., Virji, M., Pelton, S. I. (2009) Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr. Infect. Dis. J. 28, 43-48.
2. Moghaddam, S. J., Ochoa, C. E., Sethi, S., Dickey, B. F. (2011) Nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease and lung cancer. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 113-123.
3. Bandi, V., Apicella, M. A., Mason, E., Murphy, T. F., Siddiqi, A., Atmar, R. L., Greenberg, S. B. (2001) Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 164, 2114-2119.
4. De Schutter, I., De Wachter, E., Crokaert, F., Verhaegen, J., Soetens, O., Pierard, D., Malfroot, A. (2011) Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent communityacquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen. Clin. Infect. Dis. 52, 1437-1444.
5. Murphy, T. F., Sethi, S., Niederman, M. S. (2000) The role of bacteria in exacerbations of COPD. A constructive view. Chest 118, 204-209.
6. Murphy, T. F. (2000) Haemophilus influenzae in chronic bronchitis. Semin. Respir. Infect. 15, 41-51.
7. Dabernat, H., Delmas, C. (2012) Epidemiology and evolution of antibiotic resistance of Haemophilus influenzae in children 5 years of age or less in France, 2001-2008: a retrospective database analysis. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2745-2753.
8. Yamanaka, N., Hotomi, M., Billal, D. S. (2008) Clinical bacteriology and immunology in acute otitis media in children. J. Infect. Chemother. 14, 180-187.
9. Resman, F., Ristovski, M., Ahl, J., Forsgren, A., Gilsdorf, J. R., Jasir, A., Kaijser, B., Kronvall, G., Riesbeck, K. (2011) Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin. Microbiol. Infect. 17, 1638-1645.
10. Deich, R. A., Hoyer, L. C. (1982) Generation and release of DNA-binding vesicles by Haemophilus influenzae during induction and loss of competence. J. Bacteriol. 152, 855-864.
11. Hong, W., Pang, B., West-Barnette, S., Swords, W. E. (2007) Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J. Bacteriol. 189, 8300-8307.
12. Manning, A. J., Kuehn, M. J. (2011) Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol. 11, 258.
13. Unal, C. M., Schaar, V., Riesbeck, K. (2011) Bacterial outer membrane vesicles in disease and preventive medicine. Semin. Immunopathol. 33, 395-408.
14. Schaar, V., de Vries, S. P., Perez Vidakovics, M. L., Bootsma, H. J., Larsson, L., Hermans, P. W., Bjartell, A., Morgelin, M., Riesbeck, K. (2011) Multicomponent Moraxella catarrhalis outer membrane vesicles induce an inflammatory response and are internalized by human epithelial cells. Cell. Microbiol. 13, 432-449.
15. Sharpe, S. W., Kuehn, M. J., Mason, K. M. (2011) Elicitation of epithelial cell-derived immune effectors by outer membrane vesicles of nontypeable Haemophilus influenzae. Infect. Immun. 79, 4361-4369.
16. Ren, D., Nelson, K. L., Uchakin, P. N., Smith, A. L., Gu, X. X., Daines, D. A. (2012) Characterization of extended co-culture of non-typeable Haemophilus influenzae with primary human respiratory tissues. Exp. Biol. Med. (Maywood) 237, 540-547.
17. Beveridge, T. J. (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181, 4725-4733.
18. Kuehn, M. J., Kesty, N. C. (2005) Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19, 2645-2655.
19. Vidakovics, M. L., Jendholm, J., Morgelin, M., Mansson, A., Larsson, C., Cardell, L. O., Riesbeck, K. (2010) B cell activation by outer membrane vesicles-a novel virulence mechanism. PLoS Pathog. 6, e1000724.
20. Rosen, G., Naor, R., Rahamim, E., Yishai, R., Sela, M. N. (1995) Proteases of Treponema denticola outer sheath and extracellular vesicles. Infect. Immun. 63, 3973-3979.
21. Jendholm, J., Morgelin, M., Perez Vidakovics, M. L., Carlsson, M., Leffler, H., Cardell, L. O., Riesbeck, K. (2009) Superantigen-and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis. J. Immunol. 182, 4713-4720.
22. Mashburn-Warren, L. M., Whiteley, M. (2006) Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 61, 839-846.
23. Shen, Y., Giardino Torchia, M. L., Lawson, G. W., Karp, C. L., Ashwell, J. D., Mazmanian, S. K. (2012) Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12, 509-520.
24. Alaniz, R. C., Deatherage, B. L., Lara, J. C., Cookson, B. T. (2007) Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J. Immunol. 179, 7692-7701.
25. Goto, T., Bandoh, N., Yoshizaki, T., Nozawa, H., Takahara, M., Ueda, S., Hayashi, T., Harabuchi, Y. (2008) Increase in B-cell-activation factor (BAFF) and IFN-α productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin. Immunol. 126, 260-269.
26. Hardenberg, G., Planelles, L., Schwarte, C. M., van Bostelen, L., Le Huong, T., Hahne, M., Medema, J. P. (2007) Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner. Eur. J. Immunol. 37, 2900-2911.
27. Darce, J. R., Arendt, B. K., Wu, X., Jelinek, D. F. (2007) Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179, 7276-7286.
28. Abu-Rish, E. Y., Amrani, Y., Browning, M. J. (2013) Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Rheumatology (Oxford) 52, 1190-1201.
29. Meyer-Bahlburg, A., Rawlings, D. J. (2012) Differential impact of Tolllike receptor signaling on distinct B cell subpopulations. Front. Biosci. 17, 1499-1516.
30. Schneider, P. (2005) The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17, 282-289.
31. Klein, U., Rajewsky, K., Kuppers, R. (1998) Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188, 1679-1689.
32. Bernasconi, N. L., Onai, N., Lanzavecchia, A. (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101, 4500-4504.
33. Capolunghi, F., Cascioli, S., Giorda, E., Rosado, M. M., Plebani, A., Auriti, C., Seganti, G., Zuntini, R., Ferrari, S., Cagliuso, M., Quinti, I., Carsetti, R. (2008) CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180, 800-808.
34. Lin, L., Gerth, A. J., Peng, S. L. (2004) CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88. Eur. J. Immunol. 34, 1483-1487.
35. Schneider, P., Tschopp, J. (2003) BAFF and the regulation of B cell survival. Immunol. Lett. 88, 57-62.
36. Boule, M. W., Broughton, C., Mackay, F., Akira, S., Marshak-Rothstein, A., Rifkin, I. R. (2004) Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640.
37. Katsenelson, N., Kanswal, S., Puig, M., Mostowski, H., Verthelyi, D., Akkoyunlu, M. (2007) Synthetic CpG oligodeoxynucleotides augment BAFF-and APRIL-mediated immunoglobulin secretion. Eur. J. Immunol. 37, 1785-1795.